SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $921,039 | +1.6% | 25,422 | 0.0% | 0.10% | -13.6% |
| Q4 2022 | $906,802 | +5.3% | 25,422 | 0.0% | 0.12% | -25.8% |
| Q3 2022 | $861,000 | +52.9% | 25,422 | +30.5% | 0.16% | +9.7% |
| Q2 2022 | $563,000 | -10.6% | 19,487 | 0.0% | 0.14% | -4.6% |
| Q1 2022 | $630,000 | +10.9% | 19,487 | 0.0% | 0.15% | +10.9% |
| Q4 2021 | $568,000 | +9.4% | 19,487 | 0.0% | 0.14% | +5.4% |
| Q3 2021 | $519,000 | -13.5% | 19,487 | 0.0% | 0.13% | +16.1% |
| Q2 2021 | $600,000 | +17.6% | 19,487 | 0.0% | 0.11% | +14.3% |
| Q1 2021 | $510,000 | +3.9% | 19,487 | 0.0% | 0.10% | -11.7% |
| Q4 2020 | $491,000 | – | 19,487 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |